Georgetown University Hospital 20-Year Breakthrough Launched 25,000 Unrelated-Donor Transplants

Virginia Man Rob Skirdo Celebrates 20 Years Cancer-Free After First Georgetown bone marrow Transplant

USA: Two decades after volunteering for an experimental bone marrow transplant at Georgetown University Hospital, Rob Skirdo remains cancer-free and his case stands as a turning point in transplantation medicine. Diagnosed with leukemia at 33 and facing dismal odds, Skirdo chose a risky, novel course of treatment because he wanted to watch his young daughter grow up. His decision launched a program that would transform how bone marrow transplantation is done.

After an initial round of chemotherapy failed, physicians moved to a stronger regimen of chemotherapy and radiation and prepared for the pioneering transplant in 1987. The procedure carried severe risk — survival odds were estimated in the single digits — and required an intensive hospital stay of more than a month. A family member served as a living donor, providing bone marrow that gave Skirdo the chance to recover. Clinical teams navigated uncharted protocols carefully, learning and adapting step by step as they completed the first transplant at the institution.

The personal outcome was dramatic: Skirdo survived, later watched his daughter graduate from high school and is reported to be cancer-free twenty years on. His experience is credited with helping build the program into the nation’s leading bone marrow collection and procurement center. The hospital and affiliated registries have since supported about 25,000 transplants involving unrelated donors, and many bone marrow transplantations have shifted from long inpatient stays to outpatient models that allow patients to receive treatment while spending more time at home.

Skirdo’s willingness to accept risk and his sister’s living donation helped catalyze a broader change in transplantation practice — expanding donor networks, refining transplant protocols, and giving thousands of patients new chances at survival. The case remains an emblem of how a single patient’s choice can advance medical science and reshape organ and tissue transplantation for future generations.

Video originally published on 2026-02-10 18:01:17